Works by Koh, Gwanpyo


Results: 27
    1
    2
    3
    4
    5
    6
    7
    8

    Polymorphisms in Interleukin-1β and Interleukin-1 Receptor Antagonist Genes Are Associated with Kidney Failure in Korean Patients with Type 2 Diabetes mellitus.

    Published in:
    American Journal of Nephrology, 2004, v. 24, n. 4, p. 410, doi. 10.1159/000080044
    By:
    • Lee, Sang Ho;
    • Ihm, Chun-Gyoo;
    • Sohn, Seong Dong;
    • Lee, Tae Won;
    • Kim, Myung Jae;
    • Koh, Gwanpyo;
    • Oh, Seung Joon;
    • Woo, Jeoung-Taek;
    • Kim, Sung Woon;
    • Kim, Jin Woo;
    • Kim, Young Seol;
    • Lee, Byung Cheol;
    • Kim, Seong Do;
    • Cho, Byoung Soo;
    • Lee, Hee-Jae;
    • Chung, Joo-Ho
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.

    Published in:
    Diabetes & Metabolism Journal, 2022, v. 46, n. 3, p. 464, doi. 10.4093/dmj.2021.0088
    By:
    • Soo Jin Yun;
    • In-Kyung Jeong;
    • Jin-Hye Cha;
    • Juneyoung Lee;
    • Ho Chan Cho;
    • Sung Hee Choi;
    • SungWan Chun;
    • Hyun Jeong Jeon;
    • Ho-Cheol Kang;
    • Sang Soo Kim;
    • Seung-Hyun Ko;
    • Gwanpyo Koh;
    • Su Kyoung Kwon;
    • Jae Hyuk Lee;
    • Min Kyong Moon;
    • Junghyun Noh;
    • Cheol-Young Park;
    • Sungrae Kim
    Publication type:
    Article
    15
    16

    Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea.

    Published in:
    Diabetes & Metabolism Journal, 2019, v. 43, n. 4, p. 432, doi. 10.4093/dmj.2018.0092
    By:
    • Yu Mi Kang;
    • Chang Hee Jung;
    • Seung-Hwan Lee;
    • Sang-Wook Kim;
    • Kee-Ho Song;
    • Sin Gon Kim;
    • Jae Hyeon Kim;
    • Young Min Cho;
    • Tae Sun Park;
    • Bon Jeong Ku;
    • Gwanpyo Koh;
    • Dol Mi Kim;
    • Byung-Wan Lee;
    • Joong-Yeol Park
    Publication type:
    Article
    17
    18
    20
    21
    22

    Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase 2 trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2096, doi. 10.1111/dom.15080
    By:
    • Yang, Ye Seul;
    • Min, Kyung Wan;
    • Park, Seok‐O;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Hong, Eun‐Gyoung;
    • Cho, Sung Rae;
    • Won, Kyu Chang;
    • Kim, Yong Hyun;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Koh, Gwanpyo;
    • Huh, Wan;
    • Kim, Su Young;
    • Park, Kyong Soo
    Publication type:
    Article
    23

    A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1800, doi. 10.1111/dom.14766
    By:
    • Ryang, Soree;
    • Kim, Sang Soo;
    • Bae, Ji Cheol;
    • Han, Ji Min;
    • Kwon, Su Kyoung;
    • Kim, Young Il;
    • Nam‐Goong, Il Seong;
    • Kim, Eun Sook;
    • Kim, Mi‐kyung;
    • Lee, Chang Won;
    • Yoo, Soyeon;
    • Koh, Gwanpyo;
    • Kwon, Min Jeong;
    • Park, Jeong Hyun;
    • Kim, In Joo
    Publication type:
    Article
    24
    25
    26
    27